SanaClis is a full-service global contract research organization (CRO), offering a comprehensive range of services for clinical trials. In addition, SanaClis is one of the very few CRO’s that beholds integrated clinical supply chain Services, having a portfolio of solely owned state of the art GMP & GDP certified storage and distribution depots strategically placed across the European Union, and Eur-Asia (Ukraine, Russia, Georgia etc). The company was founded in 2000 by seasoned industry experts, all of whom have held executive-level positions in leading pharma companies and large global CROs.
SanaClis, our exclusive CRO sponsor, offers the provisions of its services, both as a full service offering and as standalone functional services across the world and more recently, it has expanded its operations into the USA; a crucial CRO, for US sponsors wanting to initiate trials utilising both US based sites in addition to European sites. So much so, that SanaClis has both the experience and in-depth knowledge of conducting studies in Europe across all therapeutic areas and indications. SanaClis has unique expertise in Central and Eastern Europe in particular, where access to patients is in increased significantly, produces high quality data and an all-round strategic location positively impacting the study budget for several key fundamental reasons.
How is SanaClis contributing to the future of healthcare?
SanaClis serves as a key CRO partner for companies seeking to accelerate drug development and to reduce costs. The amount of newly registered clinical trials in Central and Eastern Europe (CEE) indicates that the region is fast becoming a global hub for conducting global clinical studies. SanaClis has the capabilities and vital expertise in both traditional and emerging markets and is well positioned to assist sponsors in the execution of their clinical strategy.
SanaClis is closely monitoring the evolving pandemic situation to determine innovative changes that can be implemented to best serve patients and to prepare for the future. While patient recruitment for clinical trials can be a major challenge even under the best of circumstances, this has been further complicated by the COVID-19 pandemic. SanaClis is preparing for the future of healthcare by closely monitoring new and evolving developments in telemedicine, DTP approaches, and e-tools to create new recruitment opportunities.